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Abstract
Dysfunctional skeletal muscle calcium homeostasis plays a central role in the pathophysiology of several human and animal
skeletal muscle disorders, in particular, genetic disorders associated with ryanodine receptor 1 (RYR1) mutations, such as
malignant hyperthermia, central core disease, multiminicore disease and certain centronuclear myopathies. In addition,
aberrant skeletal muscle calcium handling is believed to play a pivotal role in the highly prevalent disorder of Thoroughbred
racehorses, known as Recurrent Exertional Rhabdomyolysis. Traditionally, such defects were studied in human and equine
subjects by examining the contractile responses of biopsied muscle strips exposed to caffeine, a potent RYR1 agonist.
However, this test is not widely available and, due to its invasive nature, is potentially less suitable for valuable animals in
training or in the human paediatric setting. Furthermore, increasingly, RYR1 gene polymorphisms (of unknown
pathogenicity and significance) are being identified through next generation sequencing projects. Consequently, we have
investigated a less invasive test that can be used to study calcium homeostasis in cultured, skin-derived fibroblasts that are
converted to the muscle lineage by viral transduction with a MyoD (myogenic differentiation 1) transgene. Similar models
have been utilised to examine calcium homeostasis in human patient cells, however, to date, there has been no detailed
assessment of the cells’ calcium homeostasis, and in particular, the responses to agonists and antagonists of RYR1. Here we
describe experiments conducted to assess calcium handling of the cells and examine responses to treatment with
dantrolene, a drug commonly used for prophylaxis of recurrent exertional rhabdomyolysis in horses and malignant
hyperthermia in humans.
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Introduction
Skeletal muscle contraction involves highly specialised and
tightly regulated mechanisms that convert electrochemical signals
to mechanotransduction. A crucial element within this machinery
is the interaction between sarcolemmal voltage-gated L-type Ca2+
channels (dihydropyridine receptors - DHPR) and sarcoplasmic
Ca2+ channels - mainly ryanodine receptors (RYR1). Upon
depolarization of the skeletal muscle transverse tubule (T-tubule)
membrane, DHPRs interact with RYR1, activating a massive
release of calcium from the sarcoplasmic reticulum (SR) into the
cytoplasm. This conversion of an electrical to a chemical signal (a
Ca2+ transient) is essential for excitation–contraction coupling
(ECC): calcium released into the cytoplasm during ECC-initiation
enables contraction of myofibrils via ATP hydrolysis from myosin
ATPases following a calcium-dependent conformational change in
the troponin-tropomyosin complex [1–3]. Relaxation, following
myofibre contraction, occurs with calcium re-uptake by the SR via
Ca2+ ATPase (SERCA1) pumps. Gradual depletion of SR calcium
storage activates a calcium entry pathway through the plasma
membrane known as store-operated calcium entry (SOCE) that
can be activated during intensive exercise [4–6]. In addition,
relatively small amounts of calcium can enter muscle cells through
a prolonged voltage-dependent (excitation) -coupled calcium entry
mechanism (ECCE) [7].
Several human and animal myopathies are associated with
dysfunction of skeletal muscle calcium regulation. These include
malignant hyperthermia (MH), a life-threatening form of rhabdo-
myolysis associated with use of volatile anaesthetic and certain
neuromuscular blocking agents that occurs in humans [8,9], dogs
[10,11] and horses [12,13], and in porcine stress syndrome, a
disorder that leads to major losses to the pork industry due to its
association with poor quality (pale, soft, exudative) meat [14,15].
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Both MH and porcine stress syndrome are associated with RYR1
mutations, as are the human muscle disorders, central core disease
(CCD), multiminicore disease (MmD), certain nemaline rod-
associated myopathies and some centronuclear myopathies [16–
24]. In CCD, evidence suggests 2 possible pathophysiological
mechanisms: RYR1-associated calcium leakage [25] and uncou-
pling of DHPR-RYR1 [23,26,27]. Brody disease (a myopathy
associated with recessive mutations in SERCA1 and delayed
muscle relaxation) is reported in humans and cattle [28–30]. In
addition, some human patients are reported with phenotypes
suggestive of calcium handling defects, including MH, but without
detectable mutations in RYR1 or other related genes [31].
Similarly, an inherited and apparent calcium handling defect that
affects 5–7% of Thoroughbred racehorses worldwide, known as
recurrent exertional rhabdomyolysis (RER) [32–34], shares
pathophysiological features with MH, but mutations in RYR1,
SERCA1 and DHPR have been excluded [35]. A likely-identical
disorder also occurs in Standardbred racehorses with a similar
prevalence [36]. RER in horses is widely treated prophylactically
with orally-administered dantrolene, an RYR1-antagonist that at
high doses can induce transient paresis [37] but that reduces
severity of exercise-induced muscle damage in some affected
horses [38]. Dantrolene is also used to treat episodes of MH in
humans, conceivably by reducing voltage dependent (excitation)
coupled calcium entry [7,39] but the mechanism of action in each
species is poorly understood.
The RYR1 cDNA’s large size (,15 kb) traditionally made
mutational analysis (and consequent study of the downstream
effect of defects in the gene), extremely labour intensive. With the
advent of next generation sequencing technologies it is feasible
rapidly to sequence the entire gene; however, and consequently,
many single nucleotide polymorphisms (SNPs) have been found in
RYR1 and without some functional assessment, it is sometimes
difficult to determine their pathogenicity, if any [40,41].
Functional assessment of MH in humans and RER in horses
traditionally relied on in vitro contraction testing (IVCT) of
isolated strips of skeletal muscle when exposed to caffeine and
other agents [42]. Furthermore, diagnosis in other calcium-related
human disorders, such as CCD and MmD still relies heavily on
muscle biopsy [43]. However, muscle biopsy in general, and the
IVCT (which requires an open biopsy) in particular, are relatively
invasive. Consequently, clinicians and researchers have looked for
alternative cell culture systems that can model calcium handling
in vitro, with a view to gaining insight into disease pathophysi-
ology, accurate diagnosis and for investigation of novel treatments.
This has been achieved in cultured myoblasts (derived from
muscle biopsy specimens) [44,45], but a system that instead utilises
fibroblasts derived from small skin biopsy samples [46,47], is
attractive, because the sampling method is less invasive, and the
primary cells are more robust in culture than myoblasts. Several
groups, including our own have converted skin derived fibroblast-
like cells to muscle cells (myotubes) in culture, utilising viral
transduction with muscle-specific transcription factors [48,49]. For
example, calcium handling - specifically caffeine and chloro-m-
cresol responses - has been studied in human skin-derived
fibroblasts-converted to myotubes through forced (adenovirally-
mediated) expression of MyoD [46,50–53]. The method is
especially attractive in the paediatric setting and in animals where
the more invasive muscle biopsy, might affect value or influence
athletic training.
Despite previously published work, there has been very little
functional analysis of skin-derived myotubes in relation to RYR1-
associated physiology; therefore, an in-depth analysis of their
excitation-calcium release dynamics seems essential if they are to
be used in confirming or characterising the phenotype of patients
in whom RYR1 mutations or a defect in calcium handling is
suspected. Validation of the use of virally-transduced, skin-derived
fibroblasts in assessment of human and animal myopathies is
extremely important, since this in vitro approach has great
potential in both clinical diagnostic and research settings. In our
earlier work, we reported a lentivirus-based system that converted
cultured equine skin-derived fibroblasts to myotubes through
expression of equine MyoD [48]. More recently, we reported the
generation of an adenoviral vector expressing (equine) MyoD that
also transforms both equine and human skin-derived fibroblasts to
myotubes [49]. Here we describe a comprehensive characterisa-
tion of this system, in the context of the modelling of skeletal
muscle calcium homeostasis in horses.
Materials and Methods
Animals and cell culture
Primary equine fibroblast-like cells were derived from skin
biopsy samples collected under local anaesthesia with sterile 4 mm
disposable punch instruments, from the left side of the mid neck
crest in 2, two-year-old, Thoroughbred racehorse geldings. Muscle
biopsy samples were obtained from 2 three-year-old Thorough-
bred geldings, euthanased for reasons unrelated to this study. The
procedure was approved by the Royal Veterinary College local
Ethics’ committee and was performed with adherence to a Home
Office Project license (PPL 70/6523) according to the Animal
(Scientific Procedures) Act 1986 of the United Kingdom. Horses
were selected on the basis of their being normal on physical
examination and through their never having been observed to
have a clinically-detectable episode of RER during their racing
career; subclinical RER was considered highly unlikely on the
basis of plasma creatine kinase and aspartate amino transferase
activities remaining within normal laboratory limits when tested
approximately fortnightly throughout an entire racing season (data
not shown).
Skin samples were collected into sterile tissue culture growth
medium (see below) and transported to the laboratory and
maintained at 4uC. Within 24 hours, biopsy specimens were cut
into 1-mm cubes with a sterile scalpel blade and placed into the
centre of 3.5 cm tissue culture dishes containing culture medium
and incubated at 37uC in an incubator containing 5% CO2. Skin
and muscle samples were routinely cultured in normal growth
medium consisting of Dulbecco modified Eagle medium, 10%
foetal bovine serum (FBS; PAA), penicillin-streptomycin (1 U/mL
and 1 mg/mL, respectively; Life Technologies) and 2 mM L-
glutamine (Life Technologies). Within 5–7 days, spindle-shaped
cells were readily visible migrating outward from the minced
tissue. Cells were passaged routinely (fewer than 10 times) until cell
numbers were high enough for subsequent experiments.
Equine cells (passage,5) and human embryonic kidney cell line
(293T) cells were routinely cultured in normal growth medium (as
above). 20% FBS-containing media was used for primary myoblast
culture (as derived and described previously [49]) prior to their
differentiation.
Virus production and myogenic conversion
Adenovirus particles expressing bicistronic eqMyoD cDNA and
eGFP from the same CMV promoter, were produced using the
system developed by the Vogelstein lab [54] as we previously
described [49]. Viral titre was determined (through infection of
293T cells) to be 2.46109 infectious units/ml; particles were stored
in aliquots at 2806C until use.
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Matrigel (1:1000, Becton-Dickinson)–coated, glass-bottomed
3.5 cm diameter dishes (MatTek Corporation) were seeded with
56104 equine skin fibroblast–like cells/well and transduced with
the adenovirus (multiplicity of infection (MOI) of 5) [49] in a final
volume (50 mL drop) on the central glass coverslip for 4 hours after
which virus-containing medium was replaced by 2 ml fresh growth
medium. 48 hours after infection, medium was replaced with
differentiation medium (MegaCell; Sigma), 2% FBS, penicillin-
streptomycin (1 U/ml and 1 mg/ml, respectively), L-glutamine
(2 mM; Sigma), 1x Non-essential Amino acids (Sigma) and beta
mercaptoethanol (0.7 ml/100 ml, Sigma). Approximately 1 week
after infection, the cells’ morphological characteristics had
changed, becoming more elongated with the formation of
myotubes. 14–21 days later, cells were used for assessment of
calcium homeostasis by fluorescence.
Calcium measurements
Myotubes (either 14 or 21 days following transduction), were
loaded with Indo-1 AM (Molecular Probes) at a concentration of
10 mM for 20 min at 37uC and then incubated for at least 1 h in
normal growth medium in order to ensure complete intracellular
de-esterification of Indo1-AM. Cells were subsequently analyzed
while being superfused with normal Tyrode solution (140 nM
NaCl, 6 mM KCl, 10 mM glucose, 10 mM HEPES, 1 mM
Mg2Cl and 2 mM CaCl2; pH 7.4) and at a constant temperature
of 37uC. After 5 min accommodation, cells were excited at
360 nm using a 100 W xenon lamp (Nikon); cellular fluorescence
signals were recorded simultaneously at 405 nm (F405) and
485 nm (F485) using photomultiplier tubes (PMT, PTI814 Thorn
EMI). Background fluorescence subtraction was routinely per-
formed using a cell-free region as zero fluorescence. Changes in
cytoplasmic calcium concentration were expressed as changes in
Figure 1. Caffeine dose response. Histogram of Indo-1 response to increasing concentrations of caffeine in adenovirally-transduced equine
myotubes. Results show mean (+/21 SEM) derived from 40 myotubes from 2 control horses sequentially exposed to 5, 10 and 20 mM caffeine at 2
and 3 weeks’ differentiation.
doi:10.1371/journal.pone.0105971.g001
Figure 2. Depolarisation with KCl. Representative experiment where skin-derived equine myotubes were subjected repeatedly to depolarization
with 60 mM KCl (red line). 10 mM caffeine responses (blue line) are shown for comparison. Note that responses are reproducible and near maximal
within approximately 4 minutes.
doi:10.1371/journal.pone.0105971.g002
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the ratio (R=F405/F485) thereby avoiding the influence of photo-
bleaching.
Cells were exposed to calcium-modifying agents through use of
a solenoid switcher device. At least 5 myotubes were studied per
dish. Maximal amplitudes of caffeine peaks after caffeine
stimulation were measured using Clampfit software (Axon
Instruments). Between 20 and 40 myotubes in total were studied
for caffeine exposure experiments, from 4 different dishes.
Thapsigargin (SERCA blocker) experiments (n = 16 tubes from
two dishes) were conducted with an initial stimulation via a pulse
of 20 mM caffeine; after Ca2+ concentration returned to baseline,
the superfusate was switched to normal Tyrode or to Ca2+-free
Tyrode solution, and then to 300 nM thapsigargin (in the
corresponding buffer, Ca2+-free or normal Tyrode solution) for
3 minutes, after which two further 20 mM caffeine stimulations
were recorded. Similar protocols were used when using tetracaine
(n = 10 tubes from two dishes) and dantrolene (n = 15 tubes from
two dishes) (50 mM and 10 mM respectively) to modify caffeine
responses. To confirm that dantrolene had no direct effect on
Indo-1 fluorescence, we compared the fluorescence emitted by
Indo-1 pentapotassium salt, at a range of calcium concentrations
(0 to 9 mM) in the presence and absence of dantrolene (10 mM).
Statistical analysis
Caffeine-response data at 2 and 3 weeks are expressed as mean
6 S.E.M. Differences in data among groups were examined by 2
way repeated measurement ANOVA followed by Tukey’s test for
post hoc analysis. Differences were considered statistically
significant when p,0.05.
Results
Caffeine responses in equine myotubes
To assess if calcium homeostasis of skin-derived myotubes is
affected by differentiation time, we studied the response of the
equine cultures to caffeine, after 2 or 3 weeks of differentiation.
Figure 1 shows peak calcium release responses when cells were
exposed to 5, 10 and 20 mM caffeine at each of the 2 time points.
We observed significantly greater calcium release (P,0.0001) at 3
weeks compared to 2 weeks at two intermediate caffeine
concentrations (5 and 10 mM) (Figure 1). As expected [49], we
observed a dose-response in caffeine-induced calcium release
(Figure 1), with a plateau (in 3 week differentiated cells) at around
10 mM caffeine. By 3 weeks of differentiation, caffeine responses
were robust and reproducible: a functional excitation-calcium
release-mechanism was indicated by the near maximal (in
comparison with 20 mM caffeine) transients when cells were
depolarised with 60 mM KCl (Figure 2). Within any one
myotube, near maximal recovery to the KCl-induced response
occurred after approximately 4 minutes (Figure 2). Cells remained
responsive to sequential KCl-induced depolarisation or caffeine-
induced calcium release as long as 30 minutes (when experiments
were terminated); there was no apparent reduction in the
amplitude of responses during this time (not shown).
Studies using calcium channel agonists/antagonists
To further characterize calcium homeostasis in our equine skin-
derived cells, we used various agonists and antagonists of calcium
regulatory proteins in calcium-containing and calcium-free solu-
tions (Figures 3 and 4). Thapsigargin, a non-competitive antago-
nist of SERCA1 [55], almost completely abolished caffeine
responses (Figure 3A). During treatment with thapsigargin there
was an increase in Indo-1 basal fluorescence, revealing accumu-
lation of cytoplasmic calcium when SERCA-1 activity is blocked.
To ascertain whether this increase in calcium concentration was
associated with sarcoplasmic Ca2+ leakage or to an influx of
extracellular Ca2+, we repeated the experiments using calcium-free
bathing solutions. In absence of extracellular calcium, thapsigargin
had the same effect: it induced a clear increase in Indo-1
fluorescence, indicative of a release of calcium from intracellular
stores in skin-derived myotubes (Figure 3B). In order to determine
whether this calcium leak was unique to skin-derived myotubes,
we performed the same experiments in 15 day-old, primary equine
myotubes derived from equine primary skeletal muscle cultures:
our experiments revealed that these cells also had detectable SR
leakage of calcium when SERCA was blocked (Figure 3C). Finally,
we investigated whether this calcium leak occurred via RYR
receptors: leakage through RYR can be blocked with tetracaine,
an agent that inhibits spontaneous calcium release at low
concentration [56]. In our model, tetracaine completely blocked
the leak of sarcoplasmic calcium (Figure 3D), suggesting that
calcium leakage occurs by way of the RYR receptor, and
consistent with results observed in skeletal and cardiac muscle,
which express RYR-1 and RYR-2 respectively [56,57].
As expected, dantrolene diminished the amplitude of the
caffeine-induced calcium transient in skin-derived myotubes
(Figures 4 A and B). We also detected a reduction in Indo1
fluorescence ratio (and hence cytoplasmic calcium concentration)
in the presence of dantrolene (Figure 4): in order to confirm that
this reduction was not an artefact associated with a direct effect of
dantrolene on the Indo1 fluorescence ratio, we examined the
influence of 10 mM dantrolene on the Indo1 fluorescence ratio at
increasing predetermined calcium concentrations (0–9 mM):
dantrolene had no effect on the Indo1 fluorescence signal
(Figure 4C) confirming that dantrolene induced a reversible
reduction in basal cytoplasmic calcium concentration in der-
mally-derived equine myotubes.
Discussion
There are several human and animal myopathies that involve
disturbances in the regulation of skeletal muscle calcium homeo-
stasis and hypersensitivity to agents that influence RYR1 channel
opening, in particular, caffeine and halothane [16–18]. The
precise nature of the perturbation can differ, even in patients with
mutations in the same gene. For example, in some CCD-affected
human patients, RYR1 mutations appear to induce an uncoupling
between DHPR and RYR1, while in other patients with MH, the
mutation makes the RYR1 channel leaky, leading to raised
cytosolic calcium concentrations [58,59]. For many suspected
RYR1 mutations however, the precise influence on muscle
calcium homeostasis is unclear: when diagnosis largely depended
on histological diagnosis following muscle biopsy, the IVCT was
considered the gold standard test, but with the advent of direct
next generation sequencing in patient diagnosis, there is likely
reluctance to perform this more invasive procedure. In the human
paediatric setting, or in valuable horses in full athletic training, use
of muscle biopsy poses an additional diagnostic dilemma. A
minimally-invasive method that can be used to investigate calcium
homeostasis defects associated with known, or suspected myopa-
thies is therefore especially attractive. Previously we revealed that
an adenovirus expressing MyoD can convert both human and
equine skin-derived fibroblasts to fusion competent myotubes, and
further, that the cells respond similarly to primary myoblasts when
exposed to incremental caffeine concentrations [49]. However, in
order to understand the cellular model’s potential for accurately
defining defects in DHPR-RYR1 coupling, and in particular,
RYR calcium leakage, it was important to evaluate in detail these
Calcium Homeostasis in Skin-Derived Myotubes
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Figure 3. Calcium responses of skin-derived myotubes, treated with specific agonists and antagonists. A) Typical transients recorded
following depolarisation with 60 mM KCl (blue line) and after exposure to 20 mM caffeine (red lines). The responses are almost abolished when the
sarcoplasmic reticulum ATP-ase (SERCA-1) is blocked with thapsigargin (green line). Note that thapsigargin treatment induces an increase in Indo-1
fluorescence, that reveals leakage of SR calcium into the cytoplasm when SERCA-1 activity is blocked. B) Effect of thapsigargin on the response of
skin-derived myotubes to caffeine, using calcium-free solution (dashed line). The increase in Ca2+ signal after the blockage of SERCA-1 supports the
hypothesis of a leaky RYR-1 channel. C) Thapsigargin treatment was assayed on myotubes derived from primary, differentiated myoblasts, confirming
that a similar leakage from the SR also occurs in these cells. D) When tetracaine is added to the perfusion system prior to the initiation of thapsigargin,
the leakage is completely blocked, suggesting that RYR-1 is responsible for the leakage of SR calcium.
doi:10.1371/journal.pone.0105971.g003
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aspects of the cells’ physiology. The model’s validation seems
especially important given that similar techniques have been used
previously to model calcium homeostasis defects in human patients
[23].
In the current experiments, we conducted a detailed character-
isation of calcium handling in dermally-derived myotubes using a
range of agonists/antagonists of the main channels involved in
EC-coupling. We detected the classical calcium release pathway
mediated by RYR activation following cellular depolarisation and
therefore revealed a functional coupling between DHPR and RYR
proteins; however, in addition, our data supports the existence of a
second, less well-defined and passive SR calcium efflux pathway,
previously referred to as RYR calcium leak, which might occur
through various proteins including RYR and translocons [58]
[60,61]. We demonstrated these skin-derived myotubes’ leak, by
blocking SERCA-1 with thapsigargin and further, by showing that
the rise in intracellular calcium occurred, even when the cells were
maintained in calcium free buffer. We also revealed that the same
response is seen in myotubes derived from primary myoblasts.
Finally, we confirmed that this passive efflux of calcium was
blocked by tetracaine, an RYR1 antagonist [60,61], revealing that
the leak occurred via this receptor and was SR-derived [58,62,63].
The on-going recycling of calcium between SR and the
cytoplasm mediated by this leak is overwhelmed by the massive
release of SR that occurs during cell depolarisation or when cells
are stimulated by caffeine. Interestingly, and as suggested
previously [64] the extent of the leak appears to contribute to
the basal cytoplasmic calcium concentration, since calcium
concentration reduced when cells (in the resting state) were
exposed to the RYR1 antagonist, dantrolene, thereby excluding
excitation-coupled calcium entry [7,39]. In horses, dantrolene has
been used both to treat [38] and prevent RER [65,66]. At higher
doses, dantrolene can induce paresis in horses [37] presumably by
limiting the extent of calcium release from the SR required for
excitation-contraction coupling and as suggested by the dimin-
ished SR response to caffeine that we observed. However, our data
suggest that the efficacy of dantrolene in equine RER and in MH,
might relate to its lowering cytoplasmic calcium concentration in
the cells’ resting state (high cell calcium concentrations can
stimulate cellular proteases and lead to rhabdomyolysis [67], [68].
Although further work is required, our data suggest that the drug
might play a role in the treatment or management of additional
RYR1-associated human or animal myopathies or other muscle
disorders with primary or secondary defects in calcium homeo-
stasis.
To date, there had been no ‘‘in depth’’ studies detailing the
calcium handling of dermally-derived, virally-transduced cells.
Our previous [48,49] and current work, reveals that these cells
respond similarly to myotubes derived from primary muscle
cultures. Whilst recognising the underlying cycling of calcium and
the extent of SR calcium leakage that occurs in such cells, the
system appears to offer a convenient, minimally-invasive model
with which to test calcium homeostasis in patients that precludes
any need for muscle biopsy. As such, the system might be more
appropriate for evaluation of racehorses in training than
intercostal muscle biopsy [69]; future work should be directed at
comparison of responses detected in dermally-derived cells from
horses and humans with known or suspected defects in cellular
calcium homeostasis and controls.
Figure 4. Effect of dantrolene on calcium transients. A) Depolarization with 60 mM KCl and 20 mM caffeine in normal buffer, followed by
exposure to sequential exposures to caffeine in the presence of 10 mM dantrolene. B) The amplitude of the caffeine transient in the absence or
presence of dantrolene. Note that dantrolene almost completely inhibits the ability of the myotubes to respond to caffeine (p,0.05) and lowers the
cytoplasmic calcium concentration of resting myotubes. C) Indo-1 fluorescence at increasing calcium concentration, in the presence or absence of
10 mM dantrolene. Note that there was no direct effect of dantrolene on Indo-1 fluorescence.
doi:10.1371/journal.pone.0105971.g004
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